Treatment of eosinophilic esophagus: Drugs, diet, or dilation?

Current Gastroenterology Reports

Volumn 9, Issue 3, 2007, Pages 181-188

  Shah, Ameesh ^b   Hirano, Ikuo ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHISTAMINIC AGENT; BUDESONIDE; CORTICOSTEROID; FLUTICASONE; FLUTICASONE PROPIONATE; HISTAMINE H1 RECEPTOR ANTAGONIST; HISTAMINE H2 RECEPTOR ANTAGONIST; INTERLEUKIN 5 ANTIBODY; METHYLPREDNISOLONE; MONTELUKAST; PLACEBO; PROTON PUMP INHIBITOR; INTERLEUKIN 5;

ALLERGY; ARTIFICIAL MILK; CHILDHOOD DISEASE; CLINICAL FEATURE; CLINICAL TRIAL; DIET RESTRICTION; DIET THERAPY; DRUG BIOAVAILABILITY; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG METABOLISM; DRUG SAFETY; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; ELEMENTAL DIET; ENDOSCOPIC ECHOGRAPHY; EOSINOPHILIA; EOSINOPHILIC ESOPHAGITIS; ESOPHAGOSCOPY; ESOPHAGUS BIOPSY; ESOPHAGUS CANDIDIASIS; ESOPHAGUS DILATATION; ESOPHAGUS STRICTURE; FAMILY HISTORY; FIBROSIS; FIRST PASS EFFECT; FOOD ALLERGY; GASTROESOPHAGEAL REFLUX; HISTOPATHOLOGY; HUMAN; HYPEREOSINOPHILIA; LONG TERM CARE; MYALGIA; NAUSEA; RECURRENT DISEASE; REVIEW; THRUSH; UNSPECIFIED SIDE EFFECT; XEROSTOMIA; ESOPHAGITIS; GENERAL AND MISCELLANEOUS PROCEDURES AND TECHNIQUES;

ADRENAL CORTEX HORMONES; DILATATION; EOSINOPHILIA; ESOPHAGITIS; HUMANS; INTERLEUKIN-5;

EID: 34249880123     PISSN: 15228037     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11894-007-0016-1     Document Type: Review

References (39)

1. Liacouras CA, Wenner WJ, Brown K, Ruchelli E: Primary eosinophilic esophagitis in children: successful treatment with oral corticosteroids. J Pediatr Gastroenterol Nutr 1998, 26:380-385.
2. Liacouras CA, Spergel JM, Ruchelli E, et al.: Eosinophilic esophagitis: a 10-year experience in 381 children. Clin Gastroenterol Hepatol 2005, 3:1198-1206.
3. Spergel JM, Beausoleil JL, Mascarenhas M, et al.: The use of skin prick tests and patch tests to identify causative foods in eosinophilic esophagitis. J Allergy Clin Immunol 2002, 109:363-368.
4. Gonsalves N, Policarpio-Nicolas M, Zhang Q, et al.: Histopathologic variability and endoscopic correlates in adults with eosinophilic esophagitis. Gastrointest Endosc 2006, 64:313-319.
5. Attwood S, Smyrk T, Demeester T, et al.: Esophageal eosinophilia with dysphagia. Dig Dis Sci 1993, 38:109-116.
6. Desai TK, Stecevic V, Chang CH: Association of eosinophilic inflammation with esophageal food impaction in adults. Gastrointest Endosc 2005, 61:795-801.
7. Liacouras CA: Eosinophilic esophagitis: treatment in 2005. Curr Opin Gastroenterol 2006, 22:147-152.
8. Patel SM, Falchuk KR: Three brothers with dysphagia caused by eosinophilic esophagitis. Gastrointest Endosc 2005, 61:165-167.
9. Remedios M, Campbell C, Jones D, et al.: Eosinophilic Esophagitis in adults: clinical, endoscopic, histologic findings, and response to fluticasone propionate. Gastrointest Endosc 2006, 63:3-12.
10. Sundaram S, Sunku B, Nelson SP, et al.: Adherent white plaques: an endoscopic finding in eosinophilic esophagitis. Journal of Pediatr Gastroenterol Nutr 2004, 38:208-212.
11. Straumann A, Spichtin H-P, Grize L, et al.: Natural history of primary eosinophilic esophagitis: a follow-up of 30 adult patients for up to 11.5 years. Gastroenterology 2003, 125:1660-1669.
12. Straumann A, Rossi L, Simon HU, et al.: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Gastrointest Endosc 1994, 124:1419-1429.
13. Fogg MI, Ruchelli E, Spergel J: Pollen and eosinophilic esophagitis. J Allergy Clin Immunol 2003, 112:796-797.
14. Konikoff MR, Noel RJ, Blanchard C, et al.: A randomized, double-blind, placebo-controlled trial of fluticasone propionate for pediatric eosinophilic esophagitis. Gastroenterology 2006, 131:1381-1391.
15. Stevoff C, Rao S, Parsons W, et al.: EUS and histopathologic correlates in eosinophilic esophagitis. Gastrointest Endosc 2001, 54:373-377.
16. Fox V, Nurko S, Teitelbaum J, et al.: High-resolution EUS in children with eosinophilic "allergic" esophagitis. Gastrointest Endosc 2003, 57:30-36.
17. Ngo P, Furuta GT, Antonioli DA, et al.: Eosinophils in the esophagus - peptic or allergic eosinophilic esophagitis? Case series of three patients with esophageal eosinophilia. Am J Gastroenterol 2006, 101:1666-1670.
18. Morrow JB, Vargo JJ, Goldblum JR, et al.: The ringed esophagus: histologic features of GERD. Am J Gastroenterol 2001, 96:984-989.
19. Baxi S, Gupta S, Swigonski N, et al.: Clinical presentation of patients with eosinophilic inflammation of the esophagus. Gastrointest Endosc 2006, 64:473-478
20. Faubion WA Jr, Perrault J, Bergart LJ, et al.: Treatment of eosinophilic esophagitis with inhaled corticosteroids. J Pediatr Gastroenterol Nutr 1998, 27:90-93.
21. Teitelbaum JE, Fox VL, Twarog FJ, et al.: Eosinophilic esophagitis in children: immunopathological analysis and response to fluticasone propionate. Gastroenterology 2002, 122:1216-225.
22. Noel RJ, Putnam PE, Collins MH, et al.: Clinical and immunopathologic effects of swallowed fluticasone for eosinophilic esophagitis. Clin Gastroenterol Hepatol 2004, 2:568-575.
23. Arora AS, Perrault J, Smyrk TC: Topical corticosteroid treatment of dysphagia due to eosinophilic esophagitis in adults. Mayo Clin Proc 2003, 78:830-835.
24. Aceves SS, Dohil R, Newbury RO, Bastian JF: Topical viscous budesonide suspension for treatment of eosinophilic esophagitis. J Allergy Clin Immunol 2005, 116:705-706.
25. Shuto J, Nagata M, Terashi Y, et al.; Esophageal candidiasis as a complication of inhaled steroid therapy. Arerugi 2003, 52:1053-1064.
26. Fukishima C, Matsuse H, Tomari S, et al.: Oral candidiasis associated with inhaled corticosteroid use: comparison of fluticasone and beclamethasone. Ann Allergy Asthma Immunol 2003, 90:646-651.
27. Attwood SE, Lewis CJ, Bronder CS, et al.: Eosinophilic oesophagitis: a novel treatment using Montelukast. Gut 2003, 52:181-185.
28. Kaplan M, Mutlu EA, Jakate S, et al.: Endoscopy in eosinophilic esophagitis: "feline" esophagus and perforation risk. Clin Gastroenterol Hepatol 2003, 1:433-437.
29. Cuss FM: Beyond the histamine receptor: effect of antihistamines on mast cells. Clin Exper Allergy 1999, 29(Suppl 3):54-59.
30. Volonakis M, Katsarou-Katsari A, Stratigos J: Etiologic factors in childhood chronic urticaria. Ann Allergy 1992, 69:61-65.
31. Sedgwick JB, Busse W: Inhibitory effect of cetirizine on cytokine-enhanced in vitro eosinophil survival. Ann Allergy Asthma Immunol 1997, 78:581-585.
32. Kelly KJ, Lazenby AJ, Rowe PC, et al.: Eosinophilic esophagitis attributed to gastroesophageal reflux: improvement with amino acid-based formula. Gastroenterology 1995, 109:1503-1512.
33. Markowitz JE, Spergel JM, Ruchelli E, et al.: Elemental diet is an effective treatment for eosinophilic esophagitis in children and adolescents. Am J Gastroenterol 2003, 98:777-782.
34. Kagalwalla A, Sentongo TA, Ritz S, et al.: Effect of six-food elimination diet on clinical and histologic outcomes in eosinophilic esophagitis. Clin Gastroenterol Hepatol 2006, 4:1097-1102.
35. Spergel JM, Andrews T, Brown-Whitehorn TF, et al.: Treatment of eosinophilic esophagitis with specific food elimination diet directed by a combination of skin prick and patch tests. Ann Allergy Asthma Immunol 2005, 95:336-343.
36. Assa'ad A: Detection of causative foods by skin prick and atopy patch tests in patients with eosinophilic esophagitis: things are not what they seem. Ann Allergy Asthma Immunol 2005, 95:309-311.
37. Potter JW, Saeian K, Staff D, et al.: Eosinophilic esophagitis in adults: an emerging problem with unique esophageal features. Gastroint Endosc 2004, 59:355-361.
38. Gonsalves N, Kirmali K, Hirano I: Safety and response of esophageal dilation in adults with eosinophilic esophagitis (EE): A single center experience of 81 patients [abstract]. Gastroenterology 2007, in press.
39. Garrett J, Jameson S, Thomson B, et al.: Anti-interleukin-5 (mepolizumab) therapy for hypereosinophilic syndromes. J Allergy Clin Immunol 2004, 113:115-119.